Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis

AIM: Cystic fibrosis (CF) patients are at high risk of developing CF-related diabetes (CFRD). In non-CF patients, liver disease, specifically steatosis and non-alcoholic fatty liver disease (NAFLD), is strongly associated with type 2 diabetes. We compared glycemic status and metabolic profiles in CF...

Descripción completa

Detalles Bibliográficos
Autores principales: Colomba, Johann, Netedu, Silvia R., Lehoux-Dubois, Catherine, Coriati, Adèle, Boudreau, Valérie, Tremblay, François, Cusi, Kenneth, Rabasa-Lhoret, Rémi, Leey, Julio A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6638946/
https://www.ncbi.nlm.nih.gov/pubmed/31318914
http://dx.doi.org/10.1371/journal.pone.0219855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6638946/
https://www.ncbi.nlm.nih.gov/pubmed/31318914
http://dx.doi.org/10.1371/journal.pone.0219855

Ejemplares similares